Joseph Klein III, Director at IONIS PHARMACEUTICALS INC (IONS), sold 8,587 shares at $42.57 ($366K) on 2024-05-03, disclosed to the SEC on 2024-05-07.
Scheduled sale ($366k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.55 | 1,070 | $46K | 12.4% |
| 2 | $42.57 | 1,318 | $56K | 15.3% |
| 3 | $42.57 | 1,318 | $56K | 15.3% |
| 4 | $42.59 | 1,269 | $54K | 14.7% |
| 5 | $42.59 | 1,269 | $54K | 14.7% |
| 6 | $42.90 | 930 |
| $40K |
| 10.9% |
| 7 | $42.94 | 682 | $29K | 8.0% |
| 8 | $42.98 | 731 | $31K | 8.6% |
| Total | $42.67 avg | 8,587 | $366K | 100% |
| Filing → |
| IONS | SELL | 2026-04-02 | $1.7M | — | Filing → |
| IONS | SELL | 2026-03-05 | $3.4M | — | Filing → |
| IONS | SELL | 2025-11-28 | $320K | — | Filing → |